Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Winrevair (sotatercept-csrk) a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension

(BUSINESS WIRE) March 26, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and...

FDA Approves Medexus's Supplemental Biologics License Application for Ixinity to Treat Hemophilia B in Pediatric Patients

March 26, 2024 - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced that the US Food and Drug Administration (FDA) recently approved Medexus's...

Ultomiris Approved in the US for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor for the treatment of...

FDA Approves Duvyzat (givinostat) for Duchenne Muscular Dystrophy

(BUSINESS WIRE)-- Mar 22, 2024 -- Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has approved Duvyzat™ (givinostat),...

FDA Approves Opsynvi (macitentan and tadalafil) for Adults with Pulmonary Arterial Hypertension

RARITAN, NJ, March 22, 2024 – Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Opsynvi® –...

Cases of Drug-Resistant Gonorrhea Have Tripled in China, Posing a Global Threat

A strain of highly antibiotic-resistant gonorrhea first emerged in China in 2016, and cases of this tough-to-treat infection have tripled there in just...

Doctor Gets First U.S. Lung-Liver Transplant for Advanced Lung Cancer

Dr. Gary Gibbon didn’t have long to live. A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently...

An ED-Based Smoking Cessation Intervention Is Feasible, Effective

A brief opportunistic intervention to support sustained tobacco smoking abstinence in the emergency department is feasible and effective, according to...

Inorganic Nitrate Treatment Cuts Rate of Contrast-Induced Nephropathy

For patients presenting with acute coronary syndromes (ACS) undergoing coronary angiography, inorganic nitrate treatment reduces the rate of contrast-induced...

Stepped Collaborative Intervention Improves Quality of Life in Cancer

A stepped collaborative care intervention can improve health-related quality of life for patients with cancer and depression, pain, or fatigue, according...

Nerve Decompression May Ease Painful Diabetic Peripheral Neuropathy

For patients with lower-extremity painful diabetic peripheral neuropathy (DPN), nerve decompression is associated with reduced pain, although these effects...

Good Sleep Can Make You Feel Young

A good night’s sleep can make you feel years younger, while crummy sleep leaves you doddering around like an oldster, a new study shows. Sleeping...

Binge Drinking Boosts Heart Risks, Especially for Women

Imbibing more than a drink per day significantly raises heart risks for all, but binge drinking is especially harmful, particularly for women, new research...

FDA Warns Consumers to Avoid Certain Topical Pain Relief Products Due to Potential for Dangerous Health Effects

The U.S. Food and Drug Administration is warning consumers not to use certain over-the-counter analgesic (pain relief) products that are marketed for topical...

Johnson & Johnson's Nipocalimab Granted U.S. FDA Fast Track Designation to Reduce the Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) in Alloimmunized Pregnant Adults

SPRING HOUSE, Pa. March 26, 2024 – Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track...

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development...

Regeneron Provides Update on Biologics License Application for Odronextamab

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued Complete Response Letters (CRLs)...

Can You Build Muscle in Old Age? Yes, and an Expert Has Tips

If you're in your 60s, 70s or even older, you might think your days of productively pumping iron are behind you. That's just not true, said Dr. Adil...

Read more news...

Recently Added

Recently added consumer and prescribing information: Winrevair, Pemgarda, Tryvio, Edurant and Edurant Ped, Tevimbra, Rezdiffra, Tyenne, Wyost, Letybo, Simlandi

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Winrevair Winrevair (sotatercept) is an activin signaling inhibitor used for the treatment of adults with pulmonary arterial hypertension.
  • Duvyzat Duvyzat (givinostat) is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy in patients 6 years of...
  • Opsynvi Opsynvi (macitentan and tadalafil) is a single tablet combination of the endothelin receptor antagonist (ERA) macitentan and the...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
  • Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.

More drugs in development